Production of Plasma Proteins for Therapeutic Use - Tapa dura

A comprehensive compilation on plasma protein production from the leading experts in the field, Production of Plasma Proteins for Therapeutic Use presents manufacturing, testing methods, and regulatory issues for plasma-derived therapeutics, a global US$10 billion industry. Culling material that until now have only been available in scattered forms across journals and books, the text features twenty-three detailed protein-by-protein chapters written by the major manufacturers of plasma protein products, addressing all aspects of these proteins, including biology, clinical use, manufacturing processes, and possible future improvements.

JOSEPH BERTOLINI, BS (HONS.), MSC, PHD, is R&D Manager at CSL Bioplasma where he has been closely involved in the technical development and improvement of immunoglobulin and albumin products. He is active in national and international conferences and industry organizations and is a strong advocate for the advancement of bioprocessing. NEIL GOSS, BS (HONS.), PHD, is Executive Director at Further Options Pty Ltd., a consulting company specializing in biotechnology and the plasma fractionation industry. He was previously Director of R&D, CSL Bioplasma and is the founding organizer for both the Plasma Product Biotechnology Meeting series and the BioProcessing Network. JOHN CURLING, BS, is a consultant in bioseparations and protein purification whose clients have included numerous biopharmaceutical, biotechnology, and vendor companies. He pioneered the development of chromatographic methods of plasma fractionation and was the President of the Process Separation Division of Pharmacia. He has acted as an advisor to the World Health Organization.